Protagonist Therapeutics, Inc (PTGX) Shareholders’ equity 2017–2025
Protagonist Therapeutics, Inc (PTGX) shareholders’ equity at each fiscal year-end, per SEC filings.
$614.7MFY2025 · since FY2017: $120.6M → $614.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $614.7M | -9.0% |
| FY2024 | $675.3M | +100.6% |
| FY2023 | $336.7M | +56.2% |
| FY2022 | $215.6M | -28.1% |
| FY2021 | $300.0M | +7.3% |
| FY2020 | $279.6M | +249.7% |
| FY2019 | $80.0M | -28.9% |
| FY2018 | $112.5M | -6.7% |
| FY2017 | $120.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice